- After a period of successful M&A activity, the Actavis management team could see $101 million in bonuses—but the decision ultimately lies with the company's investors.
- Actavis CEO Brent Saunders was heavily involved in the acquistion of both Forest Labs and Allergan. Each of these deals is associated with a "merger success reward" in the case of Forest and a "transformation incentive award" in the case of Allergan.
- Saunders has a base salary of $500,000, but when bonuses are added to that, he made more than $40 million in 2014.
It's an easy case to make: With the acquisition of Forest Labs and Allergan, the Actavis management team has added value. And that value is reflected in the stock price, which is currently trading around $297. The 52-week trading range for Actavis is $184.71 to $317.72.
Top managers stand to gain handsomely if investors approve their bonuses. Winners include not only Saunders, but also Executive Chairman Paul Bisaro, which made $35.9 million last year and other top managers, who could get as much as $10 million each in performance bonuses this year.